Non-empirical quantum chemical studies on hydration of trans- And cis- [Pt(NH3)2Cl2]. Possible role of relativistic effects

Polish Journal of Chemistry

Volumn 83, Issue 5, 2009, Pages 1013-1024

  Chojnacki, H ^a   Kuduk Jaworska, J ^b   Jaroszewicz, I ^b   Janski, J J ^b  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

Cisplatin; Interactions with water molecule; Quantum chemical calculations; Relativistic zORA calculations; Transplatin

Indexed keywords

EID: 67649639424     PISSN: 01375083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Cleare M.J. and Hoeschele J.H., Bioinorg. Chem., 2,187 (1973).
2. O'Dwyer P.J. and Stevenson J.P., Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug, Ed. B. Lippert, Wiley-VCH Weinheim, 1999, p. 31.
3. Rosenberg B., Naturwiss., 60, 399 (1973).
4. Reedijk J. and Teuben J.M., Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug, Ed. B. Lippert, Wiley-VCH Weinheim, 1999, p. 339.
5. Braddock P.D., Connors T.A., Jones N., Khokhar A.R., Melzack D.H. and Tobe M.L., Chem. Biol. Interact., 11, 145(1975).
6. Rosenberg B., Chemistry and Biochemistry of a Leading Anticancer Drug, Ed. B. Lippert, Wiley-VCH Weinheim, 1999, p. 3.
7. Hambley T.W., Coord. Chem. Rev., 166, 181 (1997).
8. Wang D. and Lippard S.J., Nat. Rev. Drug Disc, 4, 307 (2005).
9. Cleare M.J., Hydes P.C., Hepburn D.R. and Malerbi B.W., Cisplatin: Current Status and New Developments, Eds. A.W. Prestayko, S.T. Crooke, S.K. Carter, Academic Press, London, 1980, p. 49.
10. Martin R.B., Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug, Ed. B. Lippert, Wiley-VCH, Weinheim, 1999, p. 183.
11. BloeminkMJ. and Reedijk J., Metal Ions Biol. Sys., 32, 641 (1996).
12. Lepre C.L. and Lippard S.J., Nucleic Acids and Molecular Biology, Eds. F. Eckstein, Lilley D.M.J., Springer-Verlag, Berlin-Heidelberg, 1990, vol. 4, p. 9.
13. Bancroft D.P., Lepre C.A. and Lippard S.J., J. Am. Chem. Soc, 112, 6860 (1990).
14. Miller S.E. and House D.A., Inorg. Chim. Acta, 173, 53 (1990).
15. Miller S.E. and House D.A., Inorg. Chim. Acta, 187,125 (1991).
16. LeRoy A.F., Lutz R.T. and Dedrick R.L., Cancer Treat. Rep., 63, 59 (1979).
17. Hindmarsh K., House D.A. and Turnbull M.M., Inorg. Chim. Acta, 257,11 (1997).
18. Yotsuyanagi T., Usami M., Noda Y. and Nagata M., Int. J. Pharm., 246, 95 (2002).
19. Arpalahti J., Metal Ions Biol. Sys., 32, 379, (1996).
20. MikolaM. and Arpalahti J., Inorg. Chem., 33, 4439 (1994).
21. Kozelka J., Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug, Ed. Lippert B., Wiley-VCH Weinheim, 1999, p. 537.
22. Burda V, Sponer J. and Leszczynski J., Computational Chemistry: Reviews of Current Trends, Ed. J. Leszczynski, World Scientific, London, 2006, vol. 10, p. 265.
23. Burda J.V., Zeizinger M. and Leszczynski J., J. Comput. Chem., 26, 907 (2005).
24. Bradac O., Zimmermann T. and Burda J.V., J. Mol. Model, 14, 705 (2008).
25. Zhang Y, Guo Z. and You X-Z., J. Am. Chem. Soc, 123, 9378 (2001).
26. Burda J.V., Zeizinger M. and Leszczynski J., J. Chem. Phys., 120,1253 (2004).
27. Deubel D.V., J. Am. Chem. Soc, 124, 5834 (2002).
28. Deubel D.V., J. Am. Chem. Soc, 126, 5999 (2004).
29. Chojnacki H., Kuduk-Jaworska J., Jaroszewicz I. and Janski J., J. Mol. Model. (2009) (proof).
30. Chval Z. and Sip M., J. Mol. Struct. (THEOCHEM), 532, 59 ( 2000).
31. Carloni P., Sprik Z. and Andreoni W., J. Phys. Chem., B104, 823 (2000).
32. Lopes J.F., Rocha W.R., Dos Santos H.F. and De Almeida W.B., J. Chem. Phys., 128,165103 (2008).
33. Raber J., Zhu Ch. and Eriksson L.A., Mol. Phys., 102,2357 (2004).
34. 〈http://bse.pn.gov/bse.portal〉.
35. Gaussian Basis Sets for Molecular Calculations, Ed. S. Huzinaga, Elsevier, Amsterdam, 1984.
36. 〈http://OpenMOPAC.net〉.
37. GAUSSIAN-03, Rev. D-01 Gaussian Inc., Pittsburgh PA 2003.
38. Pantazis D., Chen X.-Y, Landis C.R. andNeese F., J. Chem. Theor. Comp., 4, 908 (2008).
39. LempersE. and Reedijk J., Adv. Inorg. Chem., 37,175 (1991).
40. Corden B.J., Inorg. Chim. Acta, 137,125 (1987).
41. Hanigan M.H. and Devarajan P., Cancer Then, 1,47 (2003).
42. Wang X. and Guo Z., Anticanc. Agents Med. Chem., 7,19 (2007).
43. Brabec V. and Kasparkova J., Drug Resistance Updates, 8,131 (2005).
44. Milburn G.H.W. and Truter M.R, J. Chem. Soc, A, 1609 (1966).
45. Chojnacki H., unpublished results.
46. Burda J.V. and Gu J., J. Inorg. Biochem., 102, 53 (2008).